Praxis Precision Medicines (PRAX) Other Non-Current Assets (2019 - 2026)
Praxis Precision Medicines (PRAX) posted quarterly Other Non-Current Assets of $416000.0 for Q4 2024, little changed year-over-year from $416000.0 in Q1 2024, and little changed quarter-over-quarter from $416000.0 in Q3 2024.
Praxis Precision Medicines (PRAX) Other Non-Current Assets (2019 - 2026) Analysis & Trends
Praxis Precision Medicines' Other Non-Current Assets history runs 6 years deep, the most recent figure standing at $416000.0 for Q4 2024.
- In Q4 2024, Other Non-Current Assets changed 0.0% year-over-year to $416000.0; the TTM figure through Dec 2024 stood at $416000.0 (changed 0.0% YoY), while the FY2024 annual figure was $416000.0, changed 0.0% from the prior year.
- Other Non-Current Assets for Q4 2024 stood at $416000.0, roughly flat from $416000.0 in the prior quarter.
- The five-year high for Other Non-Current Assets was $2.1 million in Q3 2020, with the low at $9000.0 in Q1 2021.
- The 5-year median for Other Non-Current Assets is $416000.0 (2021), against an average of $470333.3.
- The sharpest annual moves came in 2020 and 2022: Other Non-Current Assets tumbled 97.58% in 2020, then jumped 4522.22% in 2022.
- Praxis Precision Medicines' Other Non-Current Assets stood at $15000.0 in 2020, then jumped by 3046.67% to $472000.0 in 2021, then decreased by 11.86% to $416000.0 in 2022, then changed by 0.0% to $416000.0 in 2023, then changed by 0.0% to $416000.0 in 2024.
- Business Quant data shows PRAX's Other Non-Current Assets at $416000.0 in Q4 2024, $416000.0 in Q3 2024, and $416000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.10 Bn | 131.24 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 84.66 Bn | 76.67 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 64.59 Bn | 59.40 Bn | 1.37 Bn | 124.00 Mn |
| 4 | Moderna | 60.02 Bn | 54.88 Bn | 52.00 Mn | 618.00 Mn |
| 5 | BeOne Medicines | 41.64 Bn | 36.55 Bn | 1.53 Bn | 109.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.90 Bn | 28.59 Bn | 992.69 Mn | 65.13 Mn |
| 7 | Royalty Pharma | 27.38 Bn | 26.55 Bn | - | 62.96 Mn |
| 8 | BioNTech SE | 27.36 Bn | 8.97 Bn | 668.28 Mn | 202.31 Mn |
| 9 | Insmed | 26.66 Bn | 25.50 Bn | 358.27 Mn | 104.44 Mn |
| 10 | Praxis Precision Medicines | 10.86 Bn | 10.10 Bn | - | 643,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 643,000.00 |
| Dec 31, 2024 | 416,000.00 |
| Sep 30, 2024 | 416,000.00 |
| Jun 30, 2024 | 416,000.00 |
| Mar 31, 2024 | 416,000.00 |
| Dec 31, 2023 | 416,000.00 |
| Sep 30, 2023 | 416,000.00 |
| Jun 30, 2023 | 416,000.00 |
| Mar 31, 2023 | 416,000.00 |
| Dec 31, 2022 | 416,000.00 |
| Sep 30, 2022 | 416,000.00 |
| Jun 30, 2022 | 416,000.00 |
| Mar 31, 2022 | 416,000.00 |
| Dec 31, 2021 | 472,000.00 |
| Sep 30, 2021 | 416,000.00 |
| Jun 30, 2021 | 496,000.00 |
| Mar 31, 2021 | 9,000.00 |
| Dec 31, 2020 | 15,000.00 |
| Sep 30, 2020 | 2.07 Mn |
| Dec 31, 2019 | 620,000.00 |